Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

67%

2 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(33.3%)
Phase 3
1(33.3%)
Phase 4
1(33.3%)
3Total
N/A(1)
Phase 3(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05901961Phase 4Completed

Effectiveness and Safety of Whitfield's Solution, Zinc Oxide Nanoparticles Solution or Combination for the Treatment of Fungal Feet Infection

Role: collaborator

NCT03178747Phase 3Unknown

Tzanck Smear With Methylene Blue Stain for Herpes

Role: collaborator

NCT00142441Not ApplicableCompleted

Effect of Pulse Width on Scar Treatment Using a 595-nm Pulsed Dye Laser

Role: collaborator

All 3 trials loaded